Paris, France

Joëlle Vinh

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre National De La Recherche Scientifique, Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris, National Institute of Health and Medical Research. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joëlle Vinh. Retrieved from https://idiyas.com/inventor/joelle-vinh-dkp7kv6x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joëlle Vinh: Innovator in Diabetes Research

Introduction

Joëlle Vinh is a prominent inventor based in Paris, France. She has made significant contributions to the field of diabetes research, particularly in the development of diagnostic and therapeutic methods for Type 1 diabetes. Her innovative work has garnered attention in the scientific community.

Latest Patents

Joëlle Vinh holds a patent titled "Antigenic Peptides Deriving from Secretogranin V and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes." This patent represents her groundbreaking research and offers potential advancements in diabetes management.

Career Highlights

Throughout her career, Joëlle has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. Her roles in these organizations have allowed her to further her research and collaborate with other experts in the field.

Collaborations

Joëlle has collaborated with notable colleagues, including Roberto Mallone and Yann Verdier. These partnerships have enriched her research and contributed to the advancement of knowledge in diabetes treatment.

Conclusion

Joëlle Vinh's innovative work and dedication to diabetes research highlight her as a key figure in the scientific community. Her contributions continue to pave the way for new diagnostic and therapeutic approaches in managing Type 1 diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…